Takeda Pharmaceutical Co. announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, ...
Zencoder has launched Zenflow, a free desktop app that orchestrates AI coding agents with structured workflows, spec-driven ...
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
The increasing prevalence of chronic/acute diseases worldwide, coupled with the rising customer base in the pharma and biotechnology industry, necessitates effective client management solutions. Poor ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
The Trump administration reached a deal with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National ...
The new video introduces his as a medical rep who explains how everyday drugs reach us and what we rarely notice about them. The latest promo of Pharma, the upcoming web series headlined by Nivin ...
New Delhi: Zydus Lifesciences Ltd on Wednesday said it has entered into an exclusive licensing and commercialisation agreement with RK Pharma Inc of the US for a new sterile injectable oncology ...
Collaboration aims to streamline manufacturing linking nhs early-phase expertise eXmoor Pharma and Royal Free London NHS Foundation Trust have announced a strategic collaboration to create a seamless ...
Mumbai: Sudeep Pharma’s initial public offering (IPO) is witnessing a noticeable shift in grey market sentiment as the issue enters its final day of bidding. The grey market premium (GMP)—which ...
AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results